Norika Akashi

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Anti-polymyositis/scleroderma antibody-positive myositis exhibits greater cutaneous T cell activation than anti-ARS antibody-positive myositis.

Anti-polymyositis/scleroderma antibody-positive myositis exhibits greater cutaneous T cell activation than anti-ARS antibody-positive myositis.

Journal: JAAD international

Published: April 13, 2026

Cutaneous Lesions and Lung Squamous Cell Carcinoma Both Successfully Controlled With Chemoradiotherapy in a Patient With Cancer-Associated Clinically Amyopathic Dermatomyositis With Anti-Nuclear Matrix Protein 2 Antibodies.

Cutaneous Lesions and Lung Squamous Cell Carcinoma Both Successfully Controlled With Chemoradiotherapy in a Patient With Cancer-Associated Clinically Amyopathic Dermatomyositis With Anti-Nuclear Matrix Protein 2 Antibodies.

Journal: The Journal of dermatology

Published: January 21, 2026

Paraspinal Muscle Atrophy on Chest CT as a Prognostic Marker for Anti-Aminoacyl-tRNA Synthetase Antibody-Positive Myositis.

Paraspinal Muscle Atrophy on Chest CT as a Prognostic Marker for Anti-Aminoacyl-tRNA Synthetase Antibody-Positive Myositis.

Journal: The Journal of dermatology

Published: January 20, 2026

Novel serum autoantibodies against alpha thalassemia/mental retardation syndrome X-linked, a component of promyelocytic leukaemia nuclear bodies, in dermatomyositis.

Novel serum autoantibodies against alpha thalassemia/mental retardation syndrome X-linked, a component of promyelocytic leukaemia nuclear bodies, in dermatomyositis.

Journal: Rheumatology (Oxford, England)

Published: October 28, 2025

Polyarteritis nodosa with cutaneous manifestations localized to the upper limb, possibly caused by trauma.

Polyarteritis nodosa with cutaneous manifestations localized to the upper limb, possibly caused by trauma.

Journal: European journal of dermatology : EJD

Published: September 18, 2025

Anti-Ki/SL Antibody-Positive Deep Morphea Patient Also Positive for Anti-PL-12 and Anti-Ro60 Antibodies.

Anti-Ki/SL Antibody-Positive Deep Morphea Patient Also Positive for Anti-PL-12 and Anti-Ro60 Antibodies.

Journal: The Journal of dermatology

Published: July 02, 2025

Immune Checkpoint Inhibitor-Induced IgA Vasculitis With Abundant IgA Anti-Endothelial Cell Antibodies.

Immune Checkpoint Inhibitor-Induced IgA Vasculitis With Abundant IgA Anti-Endothelial Cell Antibodies.

Journal: The Journal of dermatology

Published: May 21, 2025

A Case of Rituximab Successfully Controlling SSc Vascular and Other Symptoms in a Pregnant Patient, Leading to a Safe Pregnancy and Delivery.

A Case of Rituximab Successfully Controlling SSc Vascular and Other Symptoms in a Pregnant Patient, Leading to a Safe Pregnancy and Delivery.

Journal: The Journal of dermatology

Published: May 07, 2025

Anti-SS-B antibody seroconversion occurring simultaneously with exacerbation of pulmonary arterial hypertension in a patient with primary Sjögren's syndrome in long-term remission.

Anti-SS-B antibody seroconversion occurring simultaneously with exacerbation of pulmonary arterial hypertension in a patient with primary Sjögren's syndrome in long-term remission.

Journal: European journal of dermatology : EJD

Published: March 20, 2025

Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.

Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.

Journal: RMD open

Published: March 15, 2025

Expanding the relevance of anti-Ki/SL beyond systemic lupus erythematosus to systemic sclerosis and dermatomyositis in in-house enzyme-linked immunosorbent assay analyses.

Expanding the relevance of anti-Ki/SL beyond systemic lupus erythematosus to systemic sclerosis and dermatomyositis in in-house enzyme-linked immunosorbent assay analyses.

Journal: Clinical and experimental dermatology

Published: November 29, 2024

Alopecia universalis and type 1 diabetes mellitus both successfully controlled with baricitinib in a patient with autoimmune polyglandular syndrome type 3A.

Alopecia universalis and type 1 diabetes mellitus both successfully controlled with baricitinib in a patient with autoimmune polyglandular syndrome type 3A.

Journal: The Journal of dermatology

Published: November 07, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026